PMC:7324763 / 65014-65135
Annnotations
LitCovid-PMC-OGER-BB
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1034 | 78-86 | SP_7 | denotes | COVID-19 |
T74844 | 78-86 | SP_7 | denotes | COVID-19 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T458 | 78-86 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T459 | 98-101 | Disease | denotes | IMM | http://purl.obolibrary.org/obo/MONDO_0020122 |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T71 | 112-114 | Chemical | denotes | ID | http://purl.obolibrary.org/obo/CHEBI_141439 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
1812 | 78-86 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T393 | 0-121 | Sentence | denotes | Another heterologous vaccine in the process of clinical trial development for COVID-19 studies is IMM-101 (CCTG ID# IC8). |